BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27326017)

  • 1. Antistreptokinase antibodies and the response to thrombolysis with streptokinase in patients with acute ST elevation myocardial infarction.
    Subhendu MS; George OK; Prakash JA
    Heart Asia; 2012; 4(1):7-10. PubMed ID: 27326017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection.
    Blackwell N; Hollins A; Gilmore G; Norton R
    J Clin Pathol; 2005 Sep; 58(9):1005-7. PubMed ID: 16126892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres.
    Lee HS; Yule S; McKenzie A; Cross S; Reid T; Davidson R; Jennings K
    Eur Heart J; 1993 Dec; 14(12):1640-3. PubMed ID: 8131761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
    Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
    Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase?
    Khan A; Nadeem S; Kokane H; Thummar A; Lokhandwala Y; Mahajan AU; Nathani PJ
    Indian Heart J; 2016; 68(3):302-5. PubMed ID: 27316481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.
    Fears R; Hearn J; Standring R; Anderson JL; Marder VJ
    Am Heart J; 1992 Aug; 124(2):305-14. PubMed ID: 1636574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcomes of acute ST-segment-elevation myocardial infarction at a tertiary-care hospital in Sri Lanka: an observational study.
    Bandara R; Medagama A; Munasinghe R; Dinamithra N; Subasinghe A; Herath J; Ratnayake M; Imbulpitiya B; Sulaiman A
    BMC Cardiovasc Disord; 2015 Jan; 15():1. PubMed ID: 25592444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility study.
    Cantor WJ; Burnstein J; Choi R; Heffernan M; Dzavik V; Lazzam C; Duic M; Fitchett D; Tan M; Wawrzyniak J; Kassam S; Dhingra S; Morrison LJ; Langer A; Goodman SG
    Can J Cardiol; 2006 Nov; 22(13):1121-6. PubMed ID: 17102829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase.
    Lee HS; Cross S; Davidson R; Reid T; Jennings K
    Eur Heart J; 1993 Jan; 14(1):84-9. PubMed ID: 8432298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India.
    Alex AG; Lahiri A; ; Geevar T; George OK
    J Postgrad Med; 2018; 64(2):80-85. PubMed ID: 29067927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction.
    Palmer S; Layland J; Adams H; Ashokkumar S; Williams PD; Judkins C; La Gerche A; Burns AT; Whitbourn RJ; MacIsaac AI; Wilson AM
    Cardiovasc Revasc Med; 2018 Dec; 19(8):917-922. PubMed ID: 29709534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
    Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program.
    Alexander T; Mullasari AS; Joseph G; Kannan K; Veerasekar G; Victor SM; Ayers C; Thomson VS; Subban V; Gnanaraj JP; Narula J; Kumbhani DJ; Nallamothu BK
    JAMA Cardiol; 2017 May; 2(5):498-505. PubMed ID: 28273293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary percutaneous transluminal coronary intervention compared with intravenous thrombolysis in patients with ST segment elevation myocardial infarction.
    Tungsubutra W; Tresukosol D; Krittayaphong R; Panchavinnin P; Phankingtongkhum R; Chotnaiwattarakul C
    J Med Assoc Thai; 2007 Apr; 90(4):672-8. PubMed ID: 17487120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.